Table 1.
Patients with IPF indicated clear needs for information in three areas
| IPF | Pirfenidone | Updates on new research and therapies |
|---|---|---|
| Greater knowledge about IPF, the causes of the disease and the number of people affected | More data regarding the efficacy and tolerability of pirfenidone, including how to practically manage tolerability issues | Information on the new drugs that are being studied for IPF, including results from clinical trials |
IPF idiopathic pulmonary fibrosis